UB Paderborn / Katalog / Suche / in CDI

Polymeric Nanoparticles for Drug Delivery in Osteoarthritis

Pharmaceutics, 2022-11, Vol.14 (12), p.2639

2022

Volltextzugriff (PDF)

Cell uptake and intracellular trafficking of bioreducible poly(amidoamine) nanoparticles for efficient mRNA translation in chondrocytes

Frontiers in bioengineering and biotechnology, 2023-11, Vol.11, p.1290871-1290871

2023

Volltextzugriff (PDF)

Polymeric Nanoparticles Enable mRNA Transfection and Its Translation in Intervertebral Disc and Human Joint Cells, Except for M1 Macrophages

Pharmaceutics, 2024-04, Vol.16 (4), p.438

2024

Volltextzugriff (PDF)

In Vitro Evaluation of a Nanoparticle-Based mRNA Delivery System for Cells in the Joint

Biomedicines, 2021-07, Vol.9 (7), p.794

2021

Volltextzugriff (PDF)

Polymeric nanoparticle-based mRNA vaccine is protective against influenza virus infection in ferrets

Molecular therapy. Nucleic acids, 2024-03, Vol.35 (1), p.102159-102159, Article 102159

2024

Volltextzugriff (PDF)

Blood-to-Brain Drug Delivery Using Nanocarriers

Drug Delivery to the Brain, p.501-526

Volltextzugriff (PDF)

Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches

2nd ed. 2022

Volltextzugriff (PDF)

Enhanced brain drug delivery: safely crossing the blood–brain barrier

Drug discovery today. Technologies, 2012, Vol.9 (2), p.e155-e160

2012

Volltextzugriff (PDF)

Abstract 5687: Development of glutathione pegylated liposomal doxorubicin (2B3-101) for the treatment of brain cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5687-5687

2012

Volltextzugriff (PDF)

Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPLS447X beneficial mutation

Human gene therapy, 2004-09, Vol.15 (9), p.906-919

2004

Volltextzugriff (PDF)

First evidence of efficacy in brain following intravenous injections of Brain-Targeted Liposome-Enzyme in the MPS II mouse model

Molecular genetics and metabolism, 2011-02, Vol.102 (2), p.S40-S40

2011

Volltextzugriff (PDF)

Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study

Arteriosclerosis, thrombosis, and vascular biology, 2006-03, Vol.26 (3), p.637

2006

Volltextzugriff (PDF)

Abstract 5537: GSH-conjugation improves efficacy of Doxil against intracranial xenografts

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.5537-5537

2010

Volltextzugriff (PDF)

Adeno-associated virus LPL S447X gene therapy in LDL receptor knockout mice

Atherosclerosis, 2007, Vol.194 (1), p.55-61

2007

Volltextzugriff (PDF)

Adeno-associated virus LPLS447X gene therapy in LDL receptor knockout mice

Atherosclerosis, 2007-09, Vol.194 (1), p.55-61

2007

Volltextzugriff (PDF)

AAV1-LPLS447X gene therapy reduces hypertriglyceridemia in apoE2 knock in mice

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2006-10, Vol.1761 (10), p.1163-1168

2006

Volltextzugriff (PDF)

AAV1-LPL S447X gene therapy reduces hypertriglyceridemia in apoE2 knock in mice

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2006, Vol.1761 (10), p.1163-1168

2006

Volltextzugriff (PDF)

Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance

Metabolism, clinical and experimental, 2005-11, Vol.54 (11), p.1499-1503

2005

Volltextzugriff (PDF)

Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers

Arteriosclerosis, thrombosis, and vascular biology, 2005-11, Vol.25 (11), p.2410

2005

Volltextzugriff (PDF)

Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes

Atherosclerosis, 2007-10, Vol.194 (2), p.446-451

2007

Volltextzugriff (PDF)

Drug targeting to the brain

BMC proceedings, 2008-09, Vol.2 (S1), p.S37-S37, Article S37

2008

Volltextzugriff (PDF)

907. Gene Therapy for Genetic Lipoprotein Lipase (LPL) Deficiency; an Update

Molecular therapy, 2005-05, Vol.11 (S1), p.S351-S351

2005

Volltextzugriff (PDF)

Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application

Human gene therapy, 2005-10, p.51014061337001

2005

Volltextzugriff (PDF)

Long-Term Correction of Murine Lipoprotein Lipase Deficiency with AAV1-Mediated Gene Transfer of the Naturally Occurring LPL S447X Beneficial Mutation

Human gene therapy, 2004-09, Vol.15 (9), p.906-919

2004

Volltextzugriff (PDF)

Chapter 19 - Recent Advances and Trends in the Brain Delivery of Small Molecule Based Cancer Therapies

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies, 2015, p.463-482

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Polymeric Nanoparticles for Drug Delivery in Osteoarthritis

Cell uptake and intracellular trafficking of bioreducible poly(amidoamine) nanoparticles for efficient mRNA translation in chondrocytes

Polymeric Nanoparticles Enable mRNA Transfection and Its Translation in Intervertebral Disc and Human Joint Cells, Except for M1 Macrophages

In Vitro Evaluation of a Nanoparticle-Based mRNA Delivery System for Cells in the Joint

Polymeric nanoparticle-based mRNA vaccine is protective against influenza virus infection in ferrets

Blood-to-Brain Drug Delivery Using Nanocarriers

Drug Delivery to the Brain: Physiological Concepts, Methodologies and Approaches

Enhanced brain drug delivery: safely crossing the blood–brain barrier

Abstract 5687: Development of glutathione pegylated liposomal doxorubicin (2B3-101) for the treatment of brain cancer

Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPLS447X beneficial mutation

First evidence of efficacy in brain following intravenous injections of Brain-Targeted Liposome-Enzyme in the MPS II mouse model

Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study

Abstract 5537: GSH-conjugation improves efficacy of Doxil against intracranial xenografts

Adeno-associated virus LPL S447X gene therapy in LDL receptor knockout mice

Adeno-associated virus LPLS447X gene therapy in LDL receptor knockout mice

AAV1-LPLS447X gene therapy reduces hypertriglyceridemia in apoE2 knock in mice

AAV1-LPL S447X gene therapy reduces hypertriglyceridemia in apoE2 knock in mice

Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance

Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers

Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes

Drug targeting to the brain

907. Gene Therapy for Genetic Lipoprotein Lipase (LPL) Deficiency; an Update

Gene Therapy for Lipoprotein Lipase Deficiency: Working Toward Clinical Application

Long-Term Correction of Murine Lipoprotein Lipase Deficiency with AAV1-Mediated Gene Transfer of the Naturally Occurring LPL S447X Beneficial Mutation

Chapter 19 - Recent Advances and Trends in the Brain Delivery of Small Molecule Based Cancer Therapies

Aktive Filter

Suchergebnisse filtern